Patrick van der Loo

Author Archives: Patrick van der Loo

Patrick van der Loo is Pfizer's Regional President for the Middle East, Russia & Africa (MERA) Region.

Patrick was appointed in December 2020 to lead operations for MERA across all therapeutic areas, including vaccines, oncology, rare diseases, internal medicine, hospitals, and inflammation and immunology.

While completing his degree in International Management, Patrick started his career in the healthcare industry, where he finished a thesis on developing Mexico's generics industry in the early 1990s. This is where Patrick developed a deep interest in the sector. Over the course of the next 20+ years he held roles across Europe, Canada, Asia-Pacific, as well as Pfizer’s New York Headquarters. He has managed some of the largest therapeutic areas in cardiovascular and neuroscience globally and led the commercial development efforts of a 500+ molecule business.

In his role at Pfizer MERA, Patrick is looking forward to bringing breakthroughs to address unmet patient needs. Together with his team, he seeks even more robust collaborations with healthcare professionals, communities, and governments to help change the lives of millions of people in the region.

Patrick currently serves as a member of the Presidential Advisory Committee on Doing Business in Africa (PAC-DBIA) under auspices of the US Department Of Commerce. He also is a Non-Executive Board Director of Pfizer Export BV. In addition, as per January 2023 he is the executive chair for PhRMA Middle East & Africa and is a board member of both the US-Africa Business Council (under US Chamber of Commerce) as well as the US-Russia Business Council.

Before his current role Patrick was the Developed Asia Lead & General Manager Pfizer Japan for the Hospital Business. Patrick speaks English, Dutch, German, Spanish and French and is passionate about healthcare, innovation, executive leadership, change management, personal and collective development.
All Articles